A baby formula maker under investigation by federal agencies for reports of consumer complaints and infant illness will consider distributing some of its products on a case-by-case basis, according to a statement from the US Food and Drug Administration.
The FDA and the US Centers for Disease Control and Prevention are currently looking into Abbott Nutrition’s powdered infant formula products. Abbott has recalled and held back Similac, Alimentum and EleCare products produced at its facility in Sturgis, Michigan, while enhanced safety testing is conducted. The formula recalls have exacerbated product shortages due to supply chain issues. As enhanced testing will take time, the FDA said it “has no objection” for Abbott to immediately release products to “individuals needing urgent, life-sustaining supplies” of certain specialty and metabolic formulas on a case-by-case basis.
